3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 2
3
Phase 2/3
2
Phase NA
1
Status
Recruiting
2
Unknown
1
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Endometrial Neoplasms
2
Interventions
Cisplatin
22
pembrolizumab
17
Drug Therapy
16
Carboplatin
15
Paclitaxel
12
Dexamethasone
12
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Bevacizumab
10
Docetaxel
9
venetoclax
8
atezolizumab
8
Pemetrexed
8
Oxaliplatin
8
Specimen Handling
7
Radiotherapy
7
Nivolumab
7
Cyclophosphamide
7
Capecitabine
7
Methotrexate
6
130-nm albumin-bound paclitaxel
6
durvalumab
5
blinatumomab
5
Cytarabine
5
Androgen Antagonists
5
tislelizumab
4
spartalizumab
4
pertuzumab
4
Vincristine
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Recruiting
×
Megestrol Acetate
×
Clear all
NCT05255653
2026-05-15
RAINBO
Leiden University Medical Center
Phase 2/3
Recruiting
1,615 enrolled
NCT07319429
2026-03-13
FEMUS
Fudan University
Phase 2/3
Recruiting
260 enrolled